🇺🇸 Cetaphil in United States

1,590 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Erythema — 267 reports (16.79%)
  2. Dry Skin — 250 reports (15.72%)
  3. Skin Burning Sensation — 176 reports (11.07%)
  4. Drug Ineffective — 164 reports (10.31%)
  5. Pruritus — 162 reports (10.19%)
  6. Skin Exfoliation — 152 reports (9.56%)
  7. Acne — 136 reports (8.55%)
  8. Condition Aggravated — 102 reports (6.42%)
  9. Rash — 92 reports (5.79%)
  10. Pain Of Skin — 89 reports (5.6%)

Source database →

Cetaphil in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Cetaphil approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Cetaphil in United States?

Galderma R&D is the originator. The local marketing authorisation holder may differ — check the official source linked above.